Zaki Sellam, MSc, MBA (Founder & CEO)
Throughout his career, Zaki has worked in scientific, executive and board functions. With more than 13 years of international experience, Zaki’s expertise lies in Biotech start-up creation, drug discovery, development & commercialization. He developed along the years a significant network in the BD&L, Tech Transfer and Financing community.
As a founder of ESN Life Sciences GmbH (specialized consulting boutique in Basel, Switzerland), he has supported several innovative biotech start-up from their creation & structuration to their financing & partnering activities. One instance is the 3 years deep support to OriBase Pharma (Oncology Biotech Start-up) resulting in a large transaction of several digit millions, hence securing the firm financing up to commercialization of its products.
Meanwhile, he co-founded various promising Biotech ventures such as Avicenna Oncology GmbH (Antibody Drug Conjugate field, Basel, Switzerland), CarboMimetics SAS (GlycoChemistry field, Paris, France), Atfal Pharma AG (Paediatrics field, Basel, Switzerland) & Genius Therapeutics SAS (Immuno-Oncology field, Bordeaux, France). Zaki could successfully secure the seed financing and several tech transfer transactions for these ventures.
Zaki holds a Master of Science degree in Biotechnology Engineering from the National School of Biotechnology in Bordeaux, France, and a Master of Business Administration from the Institute of Business Administration from Poitiers, France. He is pursing a part time PhD in Strategic Management, in collaboration with Prof Brian Smith, Hertfordshire Business School, United Kingdom. He is a native French speaker, fluent in English & Spanish, and Intermediate in German and Arabic.